This young startup is taking on a fragrance industry that hasn’t changed in a almost half century

This young startup is taking on a fragrance industry that hasn’t changed in a almost half century

Fragrance tech company Patina says it has raised $2 million in funding investors, including Betaworks and True Ventures.  The company focuses on creating new scent molecules using advanced molecular design, machine learning, and scent research. Today, most of the scent molecules used in consumer products are created by a small number of specialized labs, which…

Read More
From OpenAI’s offices to a deal with Eli Lilly — how Chai Discovery became one of the flashiest names in AI drug development

From OpenAI’s offices to a deal with Eli Lilly — how Chai Discovery became one of the flashiest names in AI drug development

Drug discovery, the art of identifying new molecules to develop pharmaceuticals, is a notoriously time-consuming and difficult process. Traditional techniques, like high-throughput screening, offer an expensive scattershot approach — one that is not often successful. However, a new breed of biotech companies are leveraging AI and advanced data technologies in an attempt to accelerate and…

Read More
#Why millions of genetically modified mosquitoes could be released across US

#Why millions of genetically modified mosquitoes could be released across US

“Why millions of genetically modified mosquitoes could be released across US” The US could soon be swarming with genetically altered mosquitoes after the Environmental Protection Agency approved a plan to test the insects. It is hoped the new altered mosquitoes will ward off their natural, disease-causing counterparts. Biotechnology company Oxitec has developed altered Aedes aegypti…

Read More
#Thiel-backed psychedelic drugmaker valued at .2B in Nasdaq debut

#Thiel-backed psychedelic drugmaker valued at $3.2B in Nasdaq debut

“#Thiel-backed psychedelic drugmaker valued at $3.2B in Nasdaq debut” Shares of Atai Life Sciences, backed by billionaire investor Peter Thiel, surged 40 percent in their U.S. stock market debut on Friday, giving the German psychedelics startup a market capitalization of $3.19 billion. The Berlin-based biotech startup, which is exploring the use of psychedelic treatments for mental illnesses,…

Read More
#Moderna applies for full FDA approval of COVID-19 vaccine

#Moderna applies for full FDA approval of COVID-19 vaccine

“#Moderna applies for full FDA approval of COVID-19 vaccine” Moderna on Tuesday asked the Food and Drug Administration for full approval of its COVID-19 vaccine in Americans 18 and older. Moderna is the second COVID vaccine maker to apply for full US approval, called a biologics license application, which would allow the company to market…

Read More